10-K: Teladoc Health Reports $200M Loss in 2025 Amid Revenue Dip

Sentiment:

Annual Report


Teladoc Health, the virtual care leader, reported a net loss of $200.3 million in 2025, a significant improvement from 2024, despite a 2% overall revenue decrease driven by its BetterHelp segment.

Capital raiseThe company may need to raise additional capital through debt or equity financings to fund operations due to a history of losses and expected future losses.Future capital requirements will depend on growth rate, subscription renewal, product development, sales and marketing expansion, new service offerings, and debt service obligations.The company may enter into arrangements to acquire or invest in additional complementary businesses, services, technologies, and intellectual property rights, which could require additional financing.
Worse than expectedTotal revenue decreased by 2% year-over-year, indicating a decline in overall business performance.The BetterHelp segment, a significant revenue contributor, experienced a 9% revenue decrease and a 5% decline in paying users.Chronic Care Program enrollment also saw a slight decrease of 1%.Average monthly revenue per U.S. Integrated Care member declined, suggesting lower monetization per member in this growing segment.

Summary

  • Teladoc Health reported a net loss of $200.3 million for the year ended December 31, 2025, an 80% improvement from the $1,001.2 million net loss in 2024.
  • Total revenue decreased by 2% to $2,529.9 million in 2025 from $2,569.6 million in 2024.
  • Integrated Care segment revenue increased by 3% to $1,579.6 million, while BetterHelp segment revenue decreased by 9% to $950.4 million.
  • Goodwill impairment charges totaled $71.8 million in 2025, significantly lower than the $790.0 million in 2024.
  • U.S. Integrated Care members increased by 9% to 101.8 million at year-end 2025.
  • Chronic Care Program enrollment decreased by 1% to 1.19 million at year-end 2025.
  • BetterHelp paying users decreased by 5% to 0.39 million for the year ended December 31, 2025.
  • Average monthly revenue per U.S. Integrated Care member decreased to $1.29 in 2025 from $1.37 in 2024.
  • Cash and cash equivalents stood at $781.1 million as of December 31, 2025.
  • The company generated $294.4 million in net cash from operating activities in 2025, a slight increase from $293.7 million in 2024.
  • Acquisitions of Catapult Health, Uplift Health Technologies, Inc., and Telecare Australia Pty Ltd. contributed approximately 2 percentage points to total revenue growth in 2025.
  • Restructuring costs were $18.8 million in 2025, primarily related to employee transition, severance, and office space reductions.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with a cautious sentiment. While the significant reduction in net loss and goodwill impairment is positive, the overall revenue decline and the decrease in BetterHelp paying users and chronic care enrollment signal underlying challenges in key growth areas. The ongoing legal proceedings and competitive pressures add to the uncertainty, despite strong liquidity and strategic acquisitions.

Positives

  • Net loss significantly improved by 80% in 2025 to $200.3 million, compared to $1,001.2 million in 2024.
  • Goodwill impairment charges were substantially lower at $71.8 million in 2025, down from $790.0 million in 2024.
  • Integrated Care segment revenue grew by 3% to $1,579.6 million in 2025.
  • U.S. Integrated Care members increased by 9% to 101.8 million, indicating strong market adoption for this segment.
  • International revenue increased by 12% to $458.2 million in 2025, demonstrating growth outside the U.S.
  • Net cash provided by operating activities slightly increased to $294.4 million in 2025, reflecting higher collections and lower incentive compensation payments.
  • The company secured a new five-year, $300.0 million senior secured revolving credit facility, enhancing financial flexibility, with no amounts drawn as of December 31, 2025.
  • The company recorded an income tax benefit of $35.2 million in 2025, primarily due to research and development tax credits and current year acquisitions.

Negatives

  • Total consolidated revenue decreased by 2% in 2025, primarily due to a decline in the BetterHelp segment.
  • BetterHelp segment revenue decreased by 9% to $950.4 million in 2025.
  • BetterHelp paying users decreased by 5% to 0.39 million in 2025, indicating a decline in the direct-to-consumer mental health market.
  • Average monthly revenue per U.S. Integrated Care member decreased to $1.29 in 2025 from $1.37 in 2024.
  • Cash and cash equivalents decreased significantly to $781.1 million in 2025 from $1,298.3 million in 2024, largely due to debt repayments.
  • The cost of customer acquisition for BetterHelp increased in 2025, and any further increase could adversely affect profitability.
  • The company has a history of cumulative losses and an accumulated deficit of $16,430.2 million as of December 31, 2025.
  • A decline in the company's market capitalization after December 31, 2025, below its carrying value, could require further goodwill impairment testing in the next reporting period.

Risks

  • History of cumulative losses and uncertainty of achieving or sustaining profitability.
  • Potential for future non-cash impairment charges for goodwill and other intangible assets, especially if market capitalization decline is sustained.
  • Risk of losing significant clients or partners, or a significant number of members/BetterHelp paying users.
  • Inability to compete successfully in competitive markets, including from large health plans and technology companies developing their own virtual care solutions.
  • Failures of cybersecurity measures, or those of vendors, exposing confidential information of the company, clients, or members.
  • Challenges in operating in the heavily regulated healthcare industry and complying with evolving data privacy regulations (PII, PHI).
  • Difficulty in recruiting, retaining, and developing a qualified workforce, particularly software engineers and providers.
  • Inability to obtain additional capital through debt or equity financings on commercially reasonable terms or at all.
  • Ongoing legal challenges to the business model or actions restricting the ability to provide services in certain jurisdictions.
  • Risks associated with a decrease in employer-sponsored healthcare or the number of applications/services subscribed to by clients.
  • Rapid technological change in the virtual care market or failure to innovate and develop new, adopted applications and services.
  • Risks related to the development and deployment of AI and machine learning, including inaccurate recommendations, data privacy concerns, and regulatory scrutiny.
  • Dependence on a limited number of third-party suppliers for medical device components, risking supply chain disruptions, tariffs, or cost inflation.
  • Exposure to political, legal, compliance, operational, regulatory, and economic risks in international operations, which are expected to increase.
  • Dependence on senior management team and inability to attract and retain highly skilled employees.
  • Failure to develop widespread brand awareness cost-effectively or widespread negative media/social media coverage.
  • BetterHelp marketing efforts may not be successful or may become more expensive, impacting costs and profitability.
  • Potential for medical liability claims against providers and the company, which may not be fully covered by insurance.
  • Failure to protect intellectual property rights could impair the ability to protect technology and brands.
  • Unanticipated changes in effective tax rate and additional tax liabilities, especially with evolving international tax laws like Pillar Two.
  • Risk that THMG Association's or Uplift Association's providers or experts could be characterized as employees, leading to employment and withholding liabilities.
  • Difficulties in integrating acquired businesses or realizing anticipated synergies from acquisitions.
  • Provisions in corporate documents and Delaware law that could make an acquisition more difficult or prevent attempts to replace management.
  • Securities class action litigation and shareholder derivative complaints, which are costly and time-consuming.

Future Outlook

The company expects to continue making significant investments to support growth, develop new applications, enhance existing solutions, and improve operating infrastructure. It anticipates continuing positive operating cash flows for 2026. Restructuring costs of $15.0 million to $20.0 million are expected in 2026, primarily for employee transition and office space reductions. The company plans to further expand BetterHelp into new international markets and increase insurance coverage for BetterHelp within the U.S. It also intends to continue investing in new expansions and innovation within its broader virtual care solution set to drive member growth, engagement, and retention.

Management Comments

  • Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience.
  • We are transforming virtual care into a catalyst for how better health happens around the world.
  • We believe that Teladoc Health is the global leader in virtual care because of our strong competitive advantages that address the most pressing challenges and trends in the delivery of healthcare around the world.
  • We believe there is significant opportunity within our existing membership base to increase engagement by continually driving awareness and usage of our solutions.
  • Mental health is an enterprise-wide initiative for us. Our mental health business is benefiting from strong secular tailwinds.
  • We expect that the THMG Association and the Uplift Association will hire more employees and rely less on contractors to ensure predictable availability of providers and a consistent member experience.
  • We believe that our existing cash and cash equivalents will be sufficient to meet our working capital, capital expenditure, and contractual obligation needs for at least the next 12 months.

Industry Context

StockSavvy.ai notes that Teladoc Health operates in a dynamic virtual care market characterized by rapid technological change and increasing competition. While the COVID-19 pandemic boosted virtual care adoption, sustaining long-term demand remains a challenge. The company's focus on integrated care and mental health aligns with broader industry trends towards holistic health and addressing unmet mental health needs. However, increased competition from specialized providers, large health plans, and tech giants like Amazon, coupled with evolving regulatory landscapes (e.g., corporate practice of medicine, data privacy, AI regulation), presents significant headwinds. The decline in BetterHelp paying users suggests that while the mental health market is expanding, direct-to-consumer models face increasing pressure, potentially from insurance integration challenges or competitive offerings from platforms like Grow Therapy, Headway, Rula, Spring Health, and Talkspace. The shift towards value-based care also means Teladoc's success increasingly hinges on demonstrating measurable clinical and cost outcomes, a trend observed across the healthcare sector.

Comparison to Industry Standards

  • Teladoc Health's Integrated Care segment, with 101.8 million U.S. members, demonstrates significant scale compared to competitors like MDLive (owned by Cigna) and American Well Corporation, positioning it as a market leader in comprehensive virtual care.
  • The 5% decrease in BetterHelp paying users contrasts with the overall growth in the virtual mental health market, suggesting that while the market is expanding, BetterHelp may be losing market share or facing increased customer acquisition costs compared to rivals such as Grow Therapy, Headway, Rula, Spring Health, and Talkspace.
  • The company's investment in AI and machine learning for care delivery and risk stratification is in line with industry leaders leveraging advanced analytics to improve outcomes and efficiency, a critical differentiator in a competitive landscape.
  • Teladoc Health's global footprint across five continents and diverse client channels is a competitive advantage, allowing it to address international market needs more comprehensively than many regionally focused competitors.
  • The company's ISO 9001, ISO 13485, ISO 27001, HITRUST, and SOC 2 Type II certifications for its cybersecurity and quality systems demonstrate a commitment to industry-leading standards for data security and operational quality, which is crucial given the sensitive nature of health data.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorJ. Eric EvansN/A2026-02-20Retirement for personal reasons; previously notified intention not to stand for reelection.
President of BetterHelpN/AFernando Madeira Rodrigues2025-11-03Adopted a Rule 10b5-1 trading plan for the sale of up to 129,115 shares of common stock through December 2026.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdoptionThe Board of Directors adopted a Code of Business Conduct and Ethics applicable to all employees, officers, and directors.N/AAims to promote ethical conduct and compliance with insider trading laws, rules, and regulations.
Policy AdoptionAdopted an insider trading policy governing the purchase, sale, and other disposition of securities by directors, officers, and employees.N/ADesigned to promote compliance with insider trading laws and listing standards.
Board OversightThe audit committee of the Board maintains primary responsibility for overseeing cybersecurity risk as part of its regular risk management program.OngoingEnsures continuous assessment and evolution of cybersecurity response in a changing environment.

Legal Proceedings

  • A securities class action complaint (Schneider v. Teladoc Health, Inc., et al.) was filed alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, based on allegedly false or misleading statements regarding business, operations, and prospects. The case was dismissed, then partially vacated and remanded on appeal, and subsequently dismissed again by the district court, with an appeal filed on July 25, 2025.
  • Multiple putative class-action lawsuits were filed against BetterHelp, Inc. in California federal and state courts and in Canada, alleging misleading patients about the use of patient data and associated violations of privacy, advertising, contract, and tort laws.
  • Data Health Partners, Inc. filed a lawsuit alleging patent infringement by certain products, including the company's blood glucose meter.
  • A securities class action complaint (Stary v. Teladoc Health, Inc., et al.) was filed, later consolidated with Waits v. Teladoc Health, Inc., et al., alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 related to advertising spend on BetterHelp. A motion to dismiss was filed on June 20, 2025.
  • Shareholder derivative complaints (Roy v. Gorevic, et al. and Brigman, et al. v. Daniel, et al.) were filed against current and former officers and directors, asserting violations of Sections 10(b) and 14(a) of the Securities Exchange Act of 1934, breach of fiduciary duty, unjust enrichment, waste of corporate assets, and gross mismanagement. Proceedings are stayed pending resolution of the Stary/Waits securities class action.

Stakeholder Impact

  • Shareholders: Experienced a decline in market capitalization and continued net losses, though the loss significantly narrowed. Ongoing legal proceedings and potential future goodwill impairments pose risks to stock value. Capital appreciation remains the sole source of gain as no cash dividends are anticipated.
  • Employees: Restructuring initiatives include employee transition and severance costs, indicating potential workforce adjustments. The company is focused on attracting, developing, and retaining talent, particularly software engineers, in a competitive job market.
  • Customers (Clients & Members): Integrated Care members increased, but BetterHelp paying users decreased. The company is investing in enhancing solutions and engagement to drive value and retention. Cybersecurity incidents or service interruptions could negatively impact customer confidence and relationships.
  • Suppliers: Dependence on a limited number of third-party suppliers for medical device components creates supply chain risks, including potential disruptions, tariffs, and cost inflation.
  • Creditors: The company has significant outstanding debt, including $1,000.0 million in convertible senior notes due 2027, and a $300.0 million revolving credit facility. Compliance with debt covenants is crucial, and future cash flows are needed to service debt obligations.

Next Steps

  • Continue to enhance Integrated Care offerings to deliver greater value for clients and members.
  • Invest in advancing capabilities and product set to drive greater value to clients across cost curve bending, access, member engagement, and quality of care.
  • Refine and enhance user experience to drive new and repeat engagement and build longer-term relationships with members.
  • Invest in new expansions and innovation within the broader virtual care solution set.
  • Leverage scaled mental health position to increase access and serve more people, including further penetrating existing client base and increasing member engagement.
  • Continue to integrate mental health into all longitudinal care programs.
  • Actively build new solutions for clients and members, such as the Wellbound employee assistance program offering.
  • Continue to expand BetterHelp into new international markets and enable users to utilize insurance benefits coverage nationwide.
  • Deepen penetration in attractive international markets where infrastructure and local expertise are already in place.
  • Evaluate potential opportunities to further expand presence into new international markets.
  • Focus on additional operational improvements to deliver consistent and reliable performance, and ensure client satisfaction and member engagement.
  • Incur pre-tax restructuring costs in the range of $15.0 million to $20.0 million for the year ending December 31, 2026, with approximately $9.0 million to $11.0 million expected in Q1 2026.
  • Monitor future guidance and state-level conformity developments regarding the One Big Beautiful Bill Act (OBBBA) and Pillar Two global minimum corporate tax rate.

Key Dates

DateDescription
2002-06-01Teladoc, Inc. incorporated in the State of Texas.
2008-10-01Teladoc, Inc. changed its state of incorporation to the State of Delaware.
2015-07-01Company adopted the 2015 Employee Stock Purchase Plan (ESPP) in connection with its initial public offering.
2018-05-08Issued $287.5 million aggregate principal amount of 1.375% convertible senior notes due 2025.
2018-08-10Teladoc, Inc. changed its corporate name to Teladoc Health, Inc.
2020-05-19Issued $1.0 billion aggregate principal amount of 1.25% convertible senior notes due 2027.
2020-06-04Livongo Health, Inc. issued $550.0 million aggregate principal amount of 0.875% convertible senior notes due 2025, which Teladoc Health later assumed.
2022-06-06Securities class action complaint (Schneider v. Teladoc Health, Inc., et al.) filed in U.S. District Court for the Southern District of New York.
2022-08-02Duplicative securities class action complaint (De Schutter v. Teladoc Health, Inc., et al.) filed, later consolidated with Schneider case.
2023-02-13Data Health Partners, Inc. filed a patent infringement lawsuit against the company.
2023-07-05Court granted defendants' motion to dismiss the Schneider complaint.
2023-07-01U.S. states began to introduce more comprehensive data protection laws.
2023-07-01EU and U.S. developed and entered into force the EU-U.S. Data Privacy Framework, UK Extension, and Swiss-U.S. Data Privacy Framework.
2023-12-01FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, adopted retrospectively by the company in 2025.
2024-05-17Securities class action complaint (Stary v. Teladoc Health, Inc., et al.) filed in U.S. District Court for the Southern District of New York.
2024-07-15Duplicative securities class action complaint (Waits v. Teladoc Health, Inc., et al.) filed, later consolidated with Stary action.
2024-09-24U.S. Court of Appeals for the Second Circuit affirmed in part, and vacated in part, the Southern District court's dismissal of the Schneider case and remanded for further proceedings.
2024-10-01Parties agreed to stay proceedings in Roy v. Gorevic, et al. derivative complaint.
2024-10-01Duplicative verified stockholder derivative complaint (Brigman, et al. v. Daniel, et al.) filed.
2024-11-01FASB issued ASU No. 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.
2024-12-10District Court appointed co-lead plaintiffs in the Stary/Waits consolidated action.
2025-01-01FASB Issued ASU No. 2025-01, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40), clarifying ASU 2024-03 effectiveness.
2025-02-24Lead plaintiffs in Stary/Waits filed an amended complaint.
2025-02-28Acquired full ownership of Catapult Health, LLC.
2025-03-21Court granted defendant's renewed motion to dismiss in the Schneider case.
2025-04-07Parties agreed to stay proceedings in Brigman, et al. v. Daniel, et al. derivative complaint.
2025-04-30Acquired Uplift Health Technologies, Inc. for $29.6 million in cash.
2025-05-01FASB issued ASU No. 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity.
2025-05-01FASB issued ASU No. 2025-04, CompensationStock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer.
2025-05-15Repaid $0.6 million outstanding principal of 1.375% convertible senior notes due 2025.
2025-06-01Repaid $550.0 million outstanding principal of 0.875% convertible senior notes due 2025 (Livongo Notes).
2025-06-01Relocated principal executive office from Purchase, New York to New York, New York.
2025-06-20Filed a motion to dismiss the Stary/Waits amended complaint.
2025-07-01FASB issued ASU No. 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets.
2025-07-04The One Big Beautiful Bill Act (OBBBA) was signed into law, restoring immediate expensing for domestic R&E expenditures.
2025-07-17Entered into a five-year, $300.0 million senior secured revolving credit facility.
2025-07-25Lead plaintiff filed an appeal of the Southern District Court's dismissal in the Schneider case.
2025-08-08Acquired full ownership of Telecare Australia Pty Ltd.
2025-09-01FASB issued ASU 2025-06, IntangiblesGoodwill and OtherInternal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.
2025-10-01Annual goodwill impairment test performed; BetterHelp's fair value exceeded carrying value, Integrated Care's approximated carrying value.
2025-11-03Fernando Madeira Rodrigues, President of BetterHelp, adopted a Rule 10b5-1 trading plan.
2025-12-01FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements.
2025-12-12CMS permanently approved a patient's home as an originating site for mental and behavioral health services.
2026-02-17There were 178,396,434 shares of common stock outstanding.
2026-02-20J. Eric Evans notified the company of his intention to retire from the Board, effective immediately.
2026-02-26Date of this Annual Report on Form 10-K.

Recommendation

hold

Teladoc Health's 2025 results show a mixed picture. While the substantial reduction in net loss and goodwill impairment is a positive step towards financial stability, the overall revenue decline and the decrease in BetterHelp paying users are concerning. The Integrated Care segment shows growth in membership, but average revenue per member is down. The company has adequate liquidity and a new credit facility, but faces significant competitive and regulatory risks, including ongoing litigation and potential future goodwill impairments. Given the improvements in loss reduction but persistent challenges in revenue growth and user engagement in a key segment, a 'hold' recommendation is appropriate. Investors should monitor the effectiveness of restructuring efforts, the performance of the BetterHelp segment, and the outcomes of legal and regulatory challenges before considering further investment.

Keywords

Virtual Care, Telehealth, Digital Health, Mental Health, Chronic Care Management, SEC Filing, 10-K, Financial Results, Healthcare Technology, Teladoc Health, BetterHelp, Goodwill Impairment, Revenue, Net Loss, Corporate Governance, Risk Factors, Cybersecurity, Acquisitions, Regulatory Compliance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.